H1BDataPointPublic data. Better decisions.
COMPANY SALARY EXPLORER

Vyluma Inc.

Exact employer profile · All loaded years

Clear filters
Matching filings2
Median yearly base wage$300,000n=1 eligible
Middle 50% of yearly wages$300,000 – $300,000
Most reported worksiteBridgewater, NJ2 matching filings
Explore this companyMost reported roleVice President, Ophthalmic New Drug Development Top worksiteBridgewater Individual recordsInspect dates & base salaries
Explore your way
Inspect, sort and export individual filings.

Salary records

2 matching H-1B filings

Export page CSV

Reported base wages in USD · pay period shown beside each amount · select a salary for case details

EmployerJob titleBase salaryLocationSubmit dateStart date
Vyluma Inc.Vice President, Ophthalmic New Drug Development

Filing details

$300,000 /yr

I-200-22326-601294
Reported wage: $300,000 / year
Annualized: $300,000
Status: Certified
Fiscal year: 2023
Decision: 2022-11-30
Employment end: 2025-12-14
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Bridgewater, NJ11/22/202212/15/2022
Vyluma Inc.Vice President, Ophthalmic New Drug Development

Filing details

$300,000 /yr

I-200-22319-588537
Reported wage: $300,000 / year
Annualized: $300,000
Status: Denied
Fiscal year: 2023
Decision: 2022-11-17
Employment end: 2025-12-14
Worker positions: 1

Employer-reported disclosure · Base wage, not total compensation.

Bridgewater, NJ11/15/202212/15/2022

About Vyluma Inc. H-1B salary records

This view contains 2 matching filings across all loaded fiscal years. The median reported yearly base wage is $300,000, based on 1 certified filings with positive yearly pay. These are filing-level observations, not unique employees or total compensation.

Read each filing in context.

Base wages preserve the disclosed pay period. Select a salary to see its case status, dates, worker positions, and annualized estimate. Salary charts use certified, positive yearly base wages; LCAs are not visa approvals. Subsidiaries and previous legal names have separate profiles. Methodology & coverage ↗